Events and Conferences

🔬 Connecting with the Global Biopharma Community

Veristat is pleased to attend BIO-Europe Spring, where biotech innovators, investors, and development leaders come together to form the partnerships that move new therapies forward. As sponsors advance programs through early and mid-stage development, success increasingly depends on disciplined planning, high-quality evidence, and regulatory clarity.

Our team looks forward to meeting with biotech leaders to discuss how Veristat helps sponsors move complex therapies forward while making every dollar of development capital count.

🔬 Connecting with the Global Clinical Data and Biostatistics Community

Veristat is pleased to attend PHUSE US Connect 2026, where leaders in biostatistics, statistical programming, data science, and regulatory standards gather to advance innovation in clinical development.

As clinical programs grow more complex and regulatory expectations around data quality continue to evolve, sponsors need statistical leadership and data strategies that transform study data into clear, submission-ready evidence. Events like PHUSE bring together the experts shaping how data standards, analytics, and statistical thinking support better regulatory outcomes.

Our team looks forward to connecting with fellow data and statistical professionals and discussing how strong evidence strategies can support efficient clinical development.

Meet Veristat at BIOCHINA & CMAC: Advancing Global Clinical Development

🔬 Connecting with the Global Biotech Community

We are pleased to be attending BIOCHINA, where innovators from across the biotech ecosystem come together to discuss the future of drug development and global regulatory strategy. As more companies pursue international pathways for approval, thoughtful clinical planning and strong data strategies have never been more important. Our team looks forward to engaging with fellow leaders, sharing perspectives, and exploring how we can help advance complex therapies from development to regulatory success.

We are also looking forward to attending the CMAC Annual Meeting and spending time with colleagues across the clinical development ecosystem. It’s so valuable to step away from day-to-day program work and have thoughtful conversations about the evolving challenges in trial design, data strategy, and regulatory expectations. So we’re excited to exchange ideas, share perspectives from complex development programs, and connect with teams advancing the next generation of therapies.

Meet Veristat at SCOPE: Powering the Future of Clinical Research February 2-5, 2026

🔬 Advancing Clinical Research with Strategic Partnership

Veristat is proud to be attending SCOPE 2026, where industry leaders gather to shape the future of clinical trials, data strategy, and operational excellence. As the clinical development landscape evolves and expectations rise, our team is ready to forge new collaborations and share insights that accelerate progress and improve outcomes.

Meet Veristat at ASH Meeting and Exposition December 6-9, 2025

Veristat is excited to attend the ASH Annual Meeting and Exposition, the world’s premier event for cutting-edge research in malignant and non-malignant hematology. This year’s meeting will take place December 6–9, 2025, bringing together global experts to share groundbreaking research and clinical advances in blood disorder research, diagnosis, and treatment.

Meet Veristat at 2nd Annual Clinical Outsourcing Group CRO Summit December 2-3, 2025

Veristat is proud to participate in the 2nd Annual Clinical Outsourcing Group CRO Summit, taking place December 2–3, 2025. This event will explore how CRO partnerships are redefining operational excellence, innovation, and flexibility across today’s evolving development landscape. 

Meet Veristat at Outsourcing in Clinical Trials New England

Meet Veristat at BIOSpain, October 7 - 9, 2025 

Meet Veristat at the TOPRA Annual Symposium

Meet Veristat at RAPS US Convergence 2025